CMS’s 2016 dialysis premium rule skipped notice and comment on the strength of an RFI, and a court enjoined it
On December 14, 2016, CMS issued an interim final rule on dialysis facilities that fund patients’ insurance premiums. It cited responses to an August request for information as good cause to skip a proposal. A federal court enjoined the rule in January 2017.
Looking Back revisits past weeks one at a time, up to the most recent, and asks what it meant for the banks, health systems and public agencies we serve. The series was written in 2026, with the benefit of hindsight, and each article says which week it looks back on.
Two-minute summaryThe dek and the first sentence of each section, quoted from the article
On December 14, 2016, CMS issued an interim final rule on dialysis facilities that fund patients’ insurance premiums. It cited responses to an August request for information as good cause to skip a proposal. A federal court enjoined the rule in January 2017.
- The week The rule grew out of a request for information.
- The request: an RFI written for planning The August 23, 2016 request sought public comment about providers and provider-affiliated organizations steering people eligible for or receiving Medicare or Medicaid into individual market plans to obtain higher payment rates. [2] It was not limited to dialysis.
- The finding: from responses to good cause The interim rule explained the ordinary path.
- The reach: disclosure duties and who carried them A footnote set the reach.
- The review: what the court weighed On the third harm, the court turned CMS’s reasoning around.
- How the rule reached different organizations Facilities that contributed to premium assistance, directly or through charities, were the rule’s direct subjects. [1] For organizations with several facilities under one parent, the contribution test operated through the parent. [1] Compliance work would have started with a map of contributions and the uses recipients could make of them.
- Objections, in order The rule’s purpose was to curb steering. [1] Its fate turned on procedure and on the record. [3] A rule aimed at a real problem can still fail if the agency cannot show good cause to skip comment.
- What compliance leaders could check Start with the map of contributions.
- With hindsight After the injunction, the Unified Agenda recorded CMS’s planned next steps for the rule.
The week
On December 14, 2016, the Centers for Medicare & Medicaid Services published an interim final rule with comment period titled Conditions for Coverage for End-Stage Renal Disease Facilities--Third Party Payment. [1] It carried file code CMS-3337-IFC and RIN 0938-AT11, and amended 42 CFR part 494. [1] The rule was to take effect on January 13, 2017, and comments were due by 5 p.m. on January 11, 2017. [1]
The rule applied to Medicare-certified dialysis facilities that make payments of premiums for individual market health plans. [1] It covered payments made directly, through a parent organization, or through a third party, in any amount. [1] The rule estimated there were approximately 6,737 Medicare-certified dialysis facilities in the United States. [1]
Its stated aims were to protect patient health and safety, improve disclosure, keep coverage decisions from being inappropriately influenced by facilities’ financial interests, and protect patients from mid-year interruptions in coverage. [1]
The rule grew out of a request for information. On August 23, 2016, CMS had published a request titled Inappropriate Steering of Individuals Eligible for or Receiving Medicare and Medicaid Benefits to Individual Market Plans. [2] It asked for comment on providers and provider-affiliated organizations steering people eligible for Medicare or Medicaid into individual market plans to obtain higher payment rates. [2]
The request said it was for information and planning purposes only. [2] It asked the public about the frequency and impact of the practice and about options to limit it, with comments due on September 22, 2016. [2]
According to the interim final rule, CMS received over 800 comments by that date, and the overwhelming majority focused on patients with end-stage renal disease. [1] The rule said all commenters on the topic believed that many facilities were paying or arranging premium payments for patients they served, and that comments indicated the practice was widespread. [1] It also recorded that more than 600 individuals receiving assistance had written in support of charitable premium assistance. [1]
The rule set out why it believed facilities had a financial interest in commercial coverage. It cited one comment that relied on financial analysts’ estimates that commercial coverage paid dialysis facilities about four times more per treatment than public coverage. [1] It also said individual market enrollees with end-stage renal disease had more than doubled between 2014 and 2015, while stating that this was not itself evidence of inappropriate behavior. [1]
The rule identified three kinds of harm to patients: effects on readiness for a kidney transplant, exposure to additional costs, and a significant risk of mid-year disruption in coverage. [1] It created two new standards in the conditions for coverage. [1]
The first, at 42 CFR 494.70(c), gave patients of covered facilities the right to annual information on coverage options, including Medicare, Medicaid, CHIP and individual market plans. [1] That information had to cover transplant costs and the facility’s contributions toward premium assistance, including the reimbursement the facility would receive under each option. [1]
The second, at 42 CFR 494.180(k), required covered facilities to disclose to the issuer each policy for which a third party payment would be made. [1] Facilities also had to obtain the issuer’s assurance that it would accept such payments for the plan year. [1] If no assurance came, the facility could not make the payments and had to take reasonable steps to stop third parties it contributed to from making them. [1]
CMS waived prior notice and comment. It said the responses to the August request were newly available evidence and that delay would be contrary to the public interest and harm patients. [1] It also said it was considering whether to prohibit third party premium payments for individual market coverage entirely for people with alternative public coverage, and sought comment on that. [1]
The interim final rule of December 14, 2016 is remembered as a fight about dialysis economics. We read it as a case study in how a regulatory record gets built and tested. CMS built its record through a request for information, then used that record to skip a proposed rule. [1] [2] A federal court found that the request was not adequate notice and enjoined the rule. [3]
Our argument is that the outcome followed from four separate features of the rulemaking, each of which a compliance leader can recognize in other rules. We take them in order:
- The request: what the August 2016 RFI asked, of whom, and on what terms.
- The finding: how the interim rule turned the RFI responses into good cause to skip notice and comment.
- The reach: what the rule required and how far its definition of a covered facility extended.
- The review: what the court weighed when it enjoined the rule.
The four parts do not overlap. The first concerns the agency’s inquiry, the second its legal justification, the third the obligations it created and the fourth the judicial response. After them, we look at how the rule reached different kinds of organizations, take the strongest objections in order, and end with what compliance leaders could check.
The case is useful because each feature left a public document behind: the request, the rule, the court’s opinion and the agenda entries that followed. [1] [2] [3] [4] A compliance team can read the same kinds of documents for any rule that affects it, and spot the same weak points early.
This is a reading of public documents, not legal advice. Health systems and dialysis organizations should check current obligations with counsel.
The request: an RFI written for planning
What it asked
The August 23, 2016 request sought public comment about providers and provider-affiliated organizations steering people eligible for or receiving Medicare or Medicaid into individual market plans to obtain higher payment rates. [2] It was not limited to dialysis. It addressed health care providers generally. [2]
CMS gave reasons for its concern. It said steering could raise overall health system costs, harm patient care through changes to provider networks and formularies, raise out-of-pocket costs and affect the individual market risk pool. [2] It asked about the frequency and impact of the practice and options to limit it. [2]
The terms it set
The request said it was issued solely for information and planning purposes. [2] It used language common to procurement notices: it was not a request for proposals and did not commit the government to contract. [2] It said CMS would not respond to questions about the policy issues it raised. [2]
Those terms tell a reader what kind of document it is. A proposed rule states the terms or substance of a rule or describes the subjects and issues involved, as the interim rule itself explained when it described the ordinary process. [1] The request did not propose regulatory text. [2]
Who answered
The interim rule summarized the response. It said CMS received over 800 comments by the September 22, 2016 deadline from patients, providers, insurers, social workers and others. [1] It said the overwhelming majority focused on patients with end-stage renal disease. [1]
The court’s later summary of the same record differed in emphasis. It said patients, advocacy groups, charities and dialysis providers among the respondents supported premium assistance and described controls against steering, while fifteen insurers criticized it. [3] The court counted 829 responses. [3] Both documents recorded support for premium assistance among respondents, and they drew different conclusions from the record. [1] [3]
Why the request mattered later
A request for information is a light tool. It lets an agency learn before it proposes. The difficulty arises when the agency later treats the responses as the record for a rule that skipped the proposal stage. Respondents who answered a general planning question did not know they were commenting on specific regulatory text. [2] [3]
For a compliance leader, the practical point is that an RFI can become the factual basis for later action. The interim rule called the RFI responses newly available evidence. [1] An organization that skipped the RFI because it was only for planning had no voice in that evidence.
Broader inquiry, narrower rule
The request covered providers and provider-affiliated organizations generally, and Medicare and Medicaid eligibility generally. [2] The rule that followed applied only to dialysis facilities and only to individual market premiums. [1] The narrowing came from the responses, which the rule said focused overwhelmingly on end-stage renal disease. [1]
That narrowing was reasonable as policy. It also meant that dialysis organizations reading the request in August had no specific signal that they, rather than providers in general, would be the subject of a rule. The court listed the request’s lack of focus on end-stage renal disease among its reasons for finding inadequate notice. [3]
What a useful response contains
A response that can serve as evidence has a few features. It describes the respondent’s actual practice, with numbers where the organization keeps them. It describes the controls in place, such as eligibility rules for assistance or separation between clinical staff and financial counseling. It states what harms the respondent has or has not observed.
A response limited to opinion gives the agency little to weigh. A response with documented practice can support the agency’s view or contradict it. Either way, it becomes part of the record a court may later read, as the court read the summary of responses in this case. [3]
Reading an RFI for signals
The August request gave signals of what might follow. It named the risk pool, network changes and out-of-pocket costs as concerns and asked about options to limit the practice. [2] A reader could have inferred that CMS was considering regulatory limits, though not their form.
Compliance teams can read RFIs this way: note the harms the agency names, the populations it mentions and the options it asks about. Those are the elements a later rule may adopt. Responses that address them with data and documented practice give the agency something other than anecdote to weigh.
The finding: from responses to good cause
The legal frame the rule invoked
The interim rule explained the ordinary path. CMS publishes a proposed rule and invites comment under the Administrative Procedure Act and section 1871(b)(1) of the Social Security Act. [1] That procedure can be waived if the agency finds good cause that notice and comment is impracticable, unnecessary or contrary to the public interest. [1]
CMS found that notice and comment would be contrary to the public interest and would cause harm to patients. [1] It also waived the usual delay in effective date, setting January 13, 2017. [1]
The three harms
CMS based its finding on three kinds of harm it drew from the RFI responses. [1] Patients could have their readiness for a kidney transplant affected. They could face additional costs. They could face a significant risk of mid-year disruption in coverage. [1]
The rule explained the mechanics. It said individual market plans may not cover some costs Medicare would, such as some living donor expenses. [1] It also said Medicare coverage of immunosuppressive drugs after a transplant depends on Part A entitlement at the time of the transplant. [1] It said late enrollment penalties and the General Enrollment Period could leave patients with gaps if they delayed Medicare. [1]
The timing argument
CMS added a timing argument. It said patients were making enrollment decisions at that time of year, with individual market Open Enrollment underway and the Medicare General Enrollment Period about to begin on January 1. [1] Waiting through a full comment cycle would, in its view, leave patients exposed through those decisions. [1]
The rule also built in a transition. For a patient not eligible for Medicaid who could enroll in Medicare only during the General Enrollment Period, and who intended to do so, the issuer disclosure standard would not apply until July 1, 2017. [1]
Comment after the fact
The interim rule still invited comment. It provided a 30-day comment period, closing on January 11, 2017. [1] That kind of comment comes after the rule is written and set to take effect. It can lead to changes in a final rule, but it does not shape the text that applies on the effective date.
The court’s opinion does not discuss that comment period. It found the procedural error was not harmless and that the plaintiffs were clearly prejudiced. [3] In our reading, the after-the-fact comment period played no part in that finding.
What the finding rested on
The finding rested on characterizations of comments. The rule said comments indicated the practice was widespread and documented a range of concerning practices. [1] It said enrollment trends raised concerns that steering may be becoming more common, while stating that the trend was not itself evidence of inappropriate behavior. [1]
In our reading, that is a candid record. CMS did not claim proof of each harm. It argued that the risks justified acting before a full comment process. The question for any reviewing court would be whether that argument met the narrow good cause standard.
What a record of harm would need
The court later pointed to the missing examples. It said the government had not provided a single example of a patient denied a transplant because of charitable assistance. [3] That remark points to what a good cause record would need: specific instances, documented, of the harms the rule cites.
An RFI built for planning does not ask for that kind of evidence. Its questions about frequency and impact invite estimates and views. [2] An agency that wants to act without comment needs harder facts than a general inquiry is designed to collect. For regulated organizations, the point runs the other way. Specific facts in a response carry more weight than general statements, whichever side they support.
The open question CMS posed
The rule did something unusual for an emergency measure. It said CMS was considering whether to prohibit third party premium payments entirely for people with alternative public coverage, and asked for comments on stricter limits. [1] It also asked about alternatives where payments would be barred absent a showing of the patient’s best interest. [1]
That request signaled that the interim rule might be a first step. It also complicated the emergency argument, because it showed CMS still developing its policy while asserting that delay for comment would cause harm.
The reach: disclosure duties and who carried them
The coverage trigger
The rule applied to any dialysis facility that made payments of premiums for individual market plans in any amount, whether directly, through a parent organization or through another entity. [1] Another entity included organizations the facility contributed to. [1]
A footnote set the reach. A facility that contributed to another organization that was able to use the funds for premium payments had to comply, even if the contributions were not directly linked to the payments. [1] The footnote said writing on a check that a contribution could not be used for premiums would not establish that the organization was unable to use it that way. [1]
The same footnote said contributions passed through one third party to another that could make premium payments would still bring a facility within the standards. [1] A facility that contributed only to an organization supporting Medicare premiums, and not individual market premiums, would not be covered. [1]
Why the trigger mattered for compliance
In our reading, this trigger turned a payment question into a mapping question. A facility could be covered without ever paying a premium itself. Its status depended on what the organizations it supported could do with its money. [1]
That kind of trigger requires records a finance team may not keep in this form. A compliance office would need a list of every contribution, the recipient’s permitted uses and whether the recipient paid individual market premiums. For a parent organization with several facilities, the answer had to be known for each facility, because the standard applied at the facility level. [1]
A hypothetical health system’s map
A hypothetical health system shows how the trigger worked. Say the system runs two certified dialysis units. Its foundation makes grants to several community charities. One of them, a kidney patient fund, can use its money for any premium, including individual market premiums.
Under the footnote, the system’s units could be covered because a related contribution reached an organization able to pay individual market premiums, even if the grant was meant for transportation. [1] The foundation’s restriction letter would not settle the question. [1] The compliance office would need to know whether the foundation’s grants counted as contributions by the facilities, a question for counsel.
The same system might also contribute to a fund that pays only Medicare premiums. Under the footnote, that contribution alone would not bring the units within the rule. [1] The map has to distinguish the two.
Disclosure to patients
The patient-rights standard required covered facilities to inform patients annually, on a timely basis for each plan year, of all available coverage options. [1] The information had to address how individual market plans would affect access to and costs for current providers, services and drugs. [1]
It also had to cover Medicare and Medicaid, including Medicare Savings Programs, each option’s coverage and costs for transplantation, and any premium assistance available. [1] Facilities had to disclose their or their parent’s contributions that subsidized individual market enrollment, including the reimbursements the facility would receive. [1]
The rule said these disclosures went to all patients of a covered facility, existing patients as well as new ones, so that patients were not treated differently based on their payer. [1] It said the information had to reflect local, current plans and would need updating at least annually. [1]
Records the rule implied
The standards also implied records beyond the disclosures themselves. A covered facility would need evidence that each patient received the annual information, what version of the information was given, and when. [1] It would need records of each issuer disclosure and each assurance or refusal. [1]
State surveyors check compliance with conditions for coverage through on-site surveys, as the rule described. [1] A survey would look for this evidence. A facility that could not show delivery of information would have had difficulty showing compliance, whatever its staff had said to patients.
Disclosure to issuers
The issuer standard required a covered facility to disclose each policy for which a third party payment would be made and to obtain the issuer’s assurance of acceptance for the plan year. [1] Without assurance, the facility could not make the payments and had to take reasonable steps to keep third parties it contributed to from making them. [1]
CMS explained its choice in a footnote. It could have required issuers to accept the payments, but said that would destabilize the individual market risk pool. [1] It said it had discouraged issuers from accepting provider third party payments since 2013. [1] It chose to require disclosure and acceptance in advance, to avoid mid-year discovery and termination. [1]
The operational load
The disclosure standards had operational consequences. Facilities would need current coverage information for each local market, a process to deliver it each year, records showing delivery, and a channel to each issuer to request assurance. [1] The rule said CMS intended to outline expectations for compliance in later guidance. [1]
The rule’s regulatory impact analysis classed it as economically significant and a major rule. [1] The court cited the agency’s estimate of compliance costs at more than $29 million a year. [3]
What the rule left untouched
The rule said it did not alter issuers’ legal obligations, including guaranteed availability and renewability under the Public Health Service Act and the Affordable Care Act’s non-discrimination rules. [1] Issuers remained bound by those rules. The duties fell on facilities.
The review: what the court weighed
The sequence
On January 6, 2017, plaintiffs filed an emergency motion to stop the rule, according to the court. [3] On January 12, 2017, before the January 13 effective date, the court entered a temporary restraining order. [3] After oral argument on January 18, it granted a preliminary injunction in a memorandum opinion filed January 25, 2017. [3]
The injunction barred HHS and its agents from implementing and enforcing 42 CFR 494.70 and 494.180 as amended by the interim rule, pending further order of the court. [3] The court said it had authority to enjoin the rule nationwide and found that appropriate. [3]
Good cause
The court read the good cause exception narrowly, following Fifth Circuit precedent. [3] It said the government had not provided a single example of a patient denied a transplant because of charitable assistance. [3] It called the second harm, additional costs, purely economic, which in its view did not supply good cause. [3]
On the third harm, the court turned CMS’s reasoning around. It found that the rule effectively gave insurers a means to stop paying once they learned of charitable assistance, and so would cause the mid-year disruptions it sought to prevent. [3] It said that at oral argument the government could not identify an emergency justifying the bypass of notice and comment. [3]
Whether the RFI was enough
The government argued the RFI gave adequate notice and made any departure from section 553(b) harmless. [3] The court disagreed. It said the RFI did not give notice that HHS was considering a rule and was not specific to end-stage renal disease. [3] It added that the RFI disclosed none of the provisions that made the rule damaging and was too open-ended for meaningful comment. [3]
The court found the plaintiffs clearly prejudiced and said the procedural violation was not harmless. [3] This part of the opinion bears directly on the first feature of the rulemaking. The request’s own terms, written for planning, were what the court relied on to find it was not notice. [2] [3]
The merits
Independent of procedure, the court found the plaintiffs likely to succeed because the rule was arbitrary and capricious. [3] It said HHS failed to consider that the rule would leave thousands of Medicare-ineligible patients without insurance. [3] It also said the rule departed from HHS’s prior guidance without acknowledging the change, citing a 1997 advisory opinion from the HHS Office of Inspector General. [3]
The court described that advisory opinion as affirming the legality of dialysis providers’ donations to charitable premium assistance and setting guidelines against disclosing those contributions to patients. [3] It said the new rule required disclosures that the guidelines prohibited. [3] We take this account from the court’s opinion; we did not open the 1997 opinion itself.
Nationwide scope
The court enjoined the rule nationwide. [3] It cited Fifth Circuit precedent upholding a nationwide injunction where partial implementation of a federal rule would detract from an integrated scheme of regulation. [3] For facilities outside Texas, the effect was the same as for those inside it: the standards could not be implemented or enforced pending further order. [3]
That mattered for compliance planning. A facility in another state did not need to bring its own case or wait for a local ruling. It did need to know the injunction existed, which required someone to follow the litigation.
Harm and the public interest
The court found irreparable injury on both sides of the plaintiffs’ case. Providers showed that some facilities would likely close if patients were forced off private plans, and compliance costs could not be recovered from the government. [3] Patients could lose access to their providers or coverage, because not all qualify for Medicare and Medicare does not cover family members. [3]
On the balance of equities, the court said HHS would suffer no comparable harm from a delay while the merits were addressed. [3] It found preserving the status quo served the public interest. [3] It did not require the plaintiffs to post security. [3]
What the court did not decide
The opinion was a ruling on a motion for a preliminary injunction. [3] It found a likelihood of success and the other factors for interim relief. It did not enter a final judgment on the merits. The court said the rule should be vacated in its discussion of good cause, but its order enjoined the rule pending further order. [3]
The opinion also did not decide whether premium assistance steers patients. It decided that HHS had not shown good cause to skip comment and was likely to lose on arbitrary-and-capricious review. [3] The underlying policy question stayed open for a properly noticed rule.
How the rule reached different organizations
Dialysis organizations
Facilities that contributed to premium assistance, directly or through charities, were the rule’s direct subjects. [1] For organizations with several facilities under one parent, the contribution test operated through the parent. [1] Compliance work would have started with a map of contributions and the uses recipients could make of them.
The issuer standard would also have required a new relationship with each individual market issuer in the facility’s area. [1] A facility serving patients covered by several issuers would need a request, a response and a record for each policy. Where an issuer refused, the facility would, in our reading, need a plan for the affected patients, including counseling on Medicare and Medicaid options. [1]
Health systems with dialysis units
A health system that runs Medicare-certified dialysis facilities is subject to the same conditions for coverage. [1] Whether it was covered turned on its own contributions. A system that donated to a charity able to pay individual market premiums could have been brought in even if its dialysis unit did not discuss premiums with patients. [1] Its foundation, finance and compliance offices would all need to know.
Issuers
Issuers received new disclosures and requests for assurance, and had to decide whether to accept payments for the plan year. [1] The rule did not require acceptance and did not change issuers’ guaranteed availability duties. [1] An issuer’s operations team would have needed a process to receive, decide and answer.
Charities
Charitable organizations were not regulated directly, because the conditions for coverage apply to facilities. [1] They were affected through their donors. A facility unable to obtain issuer assurance had to take reasonable steps to stop payments by third parties it supported. [1] That could reach a charity’s grant decisions.
Patients
Patients were the intended beneficiaries of the disclosures. [1] They were also, on the court’s account, at risk of losing coverage if issuers refused payments. [3] Both readings rest on the same mechanism: disclosure to issuers in exchange for continuity, which the court found more likely to produce disruption. [1] [3]
Social workers and financial counselors
The RFI drew comments from social workers who counsel patients about coverage. [1] The patient disclosure standard would have shaped their work, because annual coverage information would pass through them. [1] A facility’s counseling scripts and materials would need to match the rule’s content requirements, and its staff would need training on them.
Objections, in order
1. The rule was about steering, not procedure
The rule’s purpose was to curb steering. [1] Its fate turned on procedure and on the record. [3] A rule aimed at a real problem can still fail if the agency cannot show good cause to skip comment. The two questions are separate, and the court decided the procedural one first. [3]
2. An RFI is notice enough when the topic is clear
The court rejected that view on these facts, pointing to the RFI’s breadth and its silence on the rule’s key provisions. [3] A narrower RFI that described proposed requirements might fare differently. That would make it closer to a proposed rule, which is the step CMS skipped.
3. Patients faced real harm during enrollment season
CMS made that argument. [1] The court found the record lacked examples of the transplant harm and treated cost harms as economic. [3] Whether the harms were real is a separate question from whether they justified skipping comment. A court applying a narrow standard needs evidence of an emergency, and the court found none. [3]
4. Interim rules are routine at CMS
The Administrative Procedure Act and the Social Security Act both allow notice and comment to be waived for good cause, as the rule itself set out. [1] The good cause standard still applies to each one. [3] An interim rule that cites a broad RFI as its record invites the challenge this one met.
5. The disclosure model was mild
Disclosure rules can be mild. This one included a condition that could stop payments when an issuer refused assurance. [1] The court focused on that condition’s effect on coverage. [3] A disclosure duty tied to a payment ban is more than disclosure.
6. The injunction was only preliminary
It was. A preliminary injunction rests on likelihood of success, not a final judgment. [3] The later agenda entries show what CMS did next. [4] [5] [6] The hindsight section describes them.
7. Courts should defer to agency judgment on health risks
In our reading, courts give weight to agency expertise on the merits of a policy. The good cause question is procedural, and the court applied Fifth Circuit precedent reading it narrowly. [3] It said arguments of the kind HHS made could as easily justify immediate implementation of any health or safety regulation. [3] Deference on substance did not extend to skipping the process.
What compliance leaders could check
The four features give a short set of checks for health systems and dialysis organizations:
- Track federal requests for information in your sector and decide, for each, whether to respond with evidence.
- When you respond, include data and descriptions of controls, since the responses may become a rule’s record.
- When an interim final rule appears, plan for compliance by its effective date and watch the docket for challenges.
- Map every donation and payment that could reach a patient’s premium, directly or through intermediaries, and record recipients’ permitted uses.
- Keep records of what coverage options were explained to each patient and when.
- Check a rule’s status in the Unified Agenda and court records as well as the CFR text.
Where to start
Start with the map of contributions. The 2016 rule’s trigger reached funds passed through intermediaries. [1] That map is useful whatever rule applies, because it shows which payments could be questioned and by whom. It also lets a compliance office answer quickly if a regulator or insurer asks.
Then set a process for RFIs. Assign someone to read each one in the sector, note the harms and options it names, and recommend a response. [2] The cost is small. The value is a record that reflects the organization’s practice.
Finally, decide who watches the Unified Agenda. Each edition lists a rule’s stage and projected dates, as the entries for this rule show. [4] [5] [6] A change of stage, from final rule to proposed rule or to withdrawn, is a signal worth a short note to the compliance committee.
Working with the docket
The dates in this case were tight. The rule was published December 14, 2016, the motion was filed January 6, 2017, the restraining order came January 12, and the rule was to take effect January 13. [1] [3] A compliance team that waited for the court before preparing would have had no time if the court had denied relief.
The practical approach is to prepare for the effective date and track the challenge in parallel. Prepare the patient materials and the issuer process. Hold back steps that would be hard to reverse, such as ending contributions, until the rule’s status is clearer and counsel has advised.
Reporting to leadership
Rules like this one touch finance, the foundation, clinical operations and compliance at once. A short note to leadership when an interim rule appears, naming the trigger, the effective date and any challenge, lets each office prepare. A second note when a court acts closes the loop. Both notes are cheap and keep decisions in the right hands.
What the checks will not do
These checks do not settle whether premium assistance is appropriate in a given case. That is a policy and legal question for counsel and the organization’s leadership. The checks make sure the organization knows its own practice and is ready if a rule like this one returns.
With hindsight
After the injunction, the Unified Agenda recorded CMS’s planned next steps for the rule. The Spring 2017 Unified Agenda listed RIN 0938-AT11 as a final rule, CMS-3337-F, among long-term actions. [4] Its abstract said the rule would finalize the interim rule published on December 14, 2016. [4]
That entry cited section 902 of the Medicare Modernization Act. It said the provision requires Medicare final rules to publish within three years of a proposed or interim final rule, and listed a statutory final action deadline of 12/14/2019. [4]
The Fall 2017 Unified Agenda took a different approach. It retitled the item Third Party Payments for Coverage Under Qualified Health Plans, CMS-3337-P, at the proposed rule stage. [5] Its abstract described a proposed rule to set requirements for third parties that provide financial help with premiums for qualified health plan coverage. [5] In our reading, that shift meant CMS planned to restart with a proposal, the step the court found missing. [3] [5]
The agenda entries record no published proposal under that RIN. The Spring 2021 Unified Agenda listed the item under completed actions, with the timetable entry NPRM Withdrawn 03/17/2021. [6] Its abstract still described a proposed rule on third parties that provide premium assistance for individual market coverage. [6]
As checked on November 15, 2026, the eCFR text of 42 CFR 494.70(c) and 494.180(k) still contains the standards added on December 14, 2016, with citations to 81 FR 90227 and 81 FR 90228. [7] Paragraph (k) still includes the July 1, 2017 transition for patients waiting for the General Enrollment Period. [7]
The printed text does not show the injunction. The court enjoined HHS from implementing and enforcing sections 494.70 and 494.180 as amended by the interim rule, pending further order. [3] We did not find a later document in our sources that lifted the injunction or removed the text. The govinfo record for the case, No. 4:17-cv-00016, holds only the January 25, 2017 opinion. [3] Organizations should confirm the current status with counsel rather than relying on the CFR alone.
What held up from December 2016 was the court’s analysis of the request for information. The RFI’s own terms, written for planning, were the basis for the finding that it was not notice. [2] [3] CMS’s next planned step, a proposed rule, was consistent with that finding. [5]
What did not hold up was the emergency rationale. The rule’s three harms did not persuade the court to accept an interim rule without prior comment. [1] [3] The withdrawn proposal means the policy question CMS raised, whether to limit or ban third party premium payments, was not resolved through that rulemaking. [1] [6]
For health systems, the practical legacy is procedural. The conditions for coverage text in the CFR, the Unified Agenda entries and the court’s order each tell part of the story, and none tells all of it. [4] [5] [6] [7] Checking all three gives a fuller answer to what a rule requires on a given date.
The episode left a lesson for compliance teams that applies beyond dialysis. An RFI can become the record for a rule, and an interim rule can be stopped by a court in the days before it takes effect. [2] [3] Organizations that responded to the RFI with evidence, and that prepared for compliance while watching the docket, were positioned for either outcome.
Spotted an error? Tell us and we will check it and correct the article where needed.